-
RGNX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
REGENXBIO (RGNX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 58.65 mm | 58.65 mm | 58.65 mm | 58.65 mm | 58.65 mm | 58.65 mm |
Cash burn (monthly) | 382.67 k | (no burn) | 20.69 mm | 20.49 mm | 13.52 mm | 15.19 mm |
Cash used (since last report) | 2.03 mm | n/a | 109.83 mm | 108.76 mm | 71.74 mm | 80.62 mm |
Cash remaining | 56.62 mm | n/a | -51.19 mm | -50.11 mm | -13.10 mm | -21.97 mm |
Runway (months of cash) | 148.0 | n/a | -2.5 | -2.4 | -1.0 | -1.4 |
13F holders | Current |
---|---|
Total holders | 178 |
Opened positions | 40 |
Closed positions | 49 |
Increased positions | 58 |
Reduced positions | 50 |
13F shares | Current |
---|---|
Total value | 319.08 bn |
Total shares | 43.99 mm |
Total puts | 56.60 k |
Total calls | 182.20 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 5.47 mm | $42.25 bn |
Redmile | 4.79 mm | $37.06 bn |
JPM JPMorgan Chase & Co. | 4.14 mm | $31.98 bn |
Vanguard | 2.99 mm | $23.08 bn |
STT State Street | 2.19 mm | $16.90 bn |
MS Morgan Stanley | 2.00 mm | $15.49 bn |
Kiser 2012 Gift Trust | 1.91 mm | $86.72 mm |
Millennium Management | 1.32 mm | $10.22 bn |
Balyasny Asset Management | 1.19 mm | $9.18 bn |
Dimensional Fund Advisors | 1.17 mm | $9.05 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Steve Pakola | Common Stock | Grant | Acquire A | No | No | 0 | 64,293 | 0.00 | 215,980 |
2 Jan 25 | Steve Pakola | Common Stock | Payment of exercise | Dispose F | No | No | 7.73 | 13,891 | 107.38 k | 151,687 |
2 Jan 25 | Steve Pakola | Stock Options Common Stock | Grant | Acquire A | No | No | 7.86 | 103,698 | 815.07 k | 103,698 |
2 Jan 25 | Curran Simpson | Common Stock | Grant | Acquire A | No | No | 0 | 98,912 | 0.00 | 257,032 |
2 Jan 25 | Curran Simpson | Common Stock | Payment of exercise | Dispose F | No | No | 7.73 | 11,917 | 92.12 k | 158,120 |
2 Jan 25 | Curran Simpson | Stock Options Common Stock | Grant | Acquire A | No | No | 7.86 | 476,606 | 3.75 mm | 476,606 |
2 Jan 25 | Mitchell Chan | Stock Options Common Stock | Grant | Acquire A | No | No | 7.86 | 62,547 | 491.62 k | 62,547 |
2 Jan 25 | Olivier Danos | Common Stock | Grant | Acquire A | No | No | 0 | 59,347 | 0.00 | 231,800 |
2 Jan 25 | Olivier Danos | Common Stock | Payment of exercise | Dispose F | No | No | 7.73 | 12,630 | 97.63 k | 172,453 |
2 Jan 25 | Olivier Danos | Stock Options Common Stock | Grant | Acquire A | No | No | 7.86 | 95,721 | 752.37 k | 95,721 |